Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancerAnna E. Harris, Jennie Jeyapalan, Jenna E. Moyer et al.|Frontiers in Endocrinology|2022Cited by 46
The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate CancerDaisy B. Haigh, Nigel P. Mongan, Corinne L. Woodcock et al.|Cancers|2022Cited by 32
The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancerVeronika M. Metzler, Jennie Jeyapalan, Simone de Brot et al.|Frontiers in Cell and Developmental Biology|2023Cited by 22
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirinMohammed Faruk, Cheh Agustin Awasum, Sani Ibrahim et al.|PLoS ONE|2021Cited by 18
Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancerJennifer Lothion‐Roy, Corinne L. Woodcock, Daisy B. Haigh et al.|Frontiers in Genetics|2023Cited by 15